Medtronic plc (ETR:2M6)

Germany flag Germany · Delayed Price · Currency is EUR
90.51
+1.15 (1.29%)
At close: Nov 28, 2025
10.36%
Market Cap116.45B
Revenue (ttm)29.88B
Net Income (ttm)4.10B
Shares Outn/a
EPS (ttm)3.17
PE Ratio28.43
Forward PE17.93
Dividend2.54 (2.80%)
Ex-Dividend DateSep 26, 2025
Volume2,092
Average Volume2,141
Open90.52
Previous Close89.36
Day's Range90.34 - 91.23
52-Week Range70.58 - 91.50
Beta0.74
RSI71.30
Earnings DateNov 18, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]

Sector Healthcare
Founded 1949
Employees 95,000
Stock Exchange Deutsche Börse Xetra
Ticker Symbol 2M6
Full Company Profile

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD Financial Statements

News

3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio

Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-t...

19 hours ago - The Motley Fool

Best Dividend Aristocrats For December 2025

The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...

1 day ago - Seeking Alpha

Robotics can 'democratize good healthcare' worldwide: Medtronic CEO

Medtronic Chairman and CEO Geoffrey Martha discusses the company's latest robotic innovation and how robotics can impact healthcare on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusin...

3 days ago - Fox Business

5 Top Dividend Stocks to Buy in November

For investors, it's generally wise to buy and hold companies that continually raise their dividends. There are deals in energy, healthcare, consumer staples, and even the tech space.

6 days ago - The Motley Fool

ISRG vs. MDT: A High-Tech Robotics Faceoff in the Race for Leadership

Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.

6 days ago - Nasdaq

This Medtech Giant's Stock Is Soaring. Should You Buy It Ahead of 2026?

Medtronic is proving that it's a reliable company to invest in.

6 days ago - The Motley Fool

Which 'Dividend Prince' Will Become The Next King In 2 Years?

Medtronic is nearing a crowning achievement.

7 days ago - The Motley Fool

What Are the Best Healthcare Stocks to Buy Now? I Think It's Intuitive Surgical (ISRG) -- or, to Play It Safer, Medtronic (MDT)

Robotic surgery is a hot field, with new entrants coming.

7 days ago - The Motley Fool

MDT Quantitative Stock Analysis

Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...

8 days ago - Nasdaq

Insider Sell: Gregory Smith Sells 30,000 Shares of Medtronic PLC

Insider Sell: Gregory Smith Sells 30,000 Shares of Medtronic PLC

9 days ago - GuruFocus

2 Fantastic Dividend Stocks to Buy and Hold Forever

Abbott and Medtronic are innovative healthcare leaders that generate consistent revenue and profits. They also have attractive long-term prospects and have consistently raised their dividend payouts.

9 days ago - The Motley Fool

Barclays Raises Medtronic (MDT) Price Target, Maintains Overweight Rating | MDT Stock News

Barclays Raises Medtronic (MDT) Price Target, Maintains Overweight Rating | MDT Stock News

10 days ago - GuruFocus

Medtronic (MDT) Analyst Rating Update: Price Target Raised to $110 | MDT Stock News

Medtronic (MDT) Analyst Rating Update: Price Target Raised to $110 | MDT Stock News

10 days ago - GuruFocus

Medtronic (MDT) Stock Signal: Should You Sell the Price Spike? - 20 November 2025

A strong earnings report led to a post-earnings spike, despite muted revenue guidance and declining profit margins. Should you sell the price spike?

10 days ago - DailyForex

MDT Factor-Based Stock Analysis

Below is Validea's guru fundamental report for MEDTRONIC PLC (MDT). Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...

11 days ago - Nasdaq

These Analysts Increase Their Forecasts On Medtronic After Strong Q2 Earnings

Medtronic Plc (NYSE: MDT) on Tuesday reported strong second- quarter 2026 results . The company’s sales reached $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% in...

11 days ago - Benzinga

These Analysts Increase Their Forecasts On Medtronic After Strong Q2 Earnings

Medtronic Plc (NYSE: MDT) on Tuesday reported strong second-quarter 2026 results.

11 days ago - Benzinga

Medtronic Stock Sees RS Rating Pumps Higher

Medtronic shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 67 to 82.

11 days ago - Investor's Business Daily

Morgan Stanley Raises Medtronic (MDT) Price Target to $117 | MDT Stock News

Morgan Stanley Raises Medtronic (MDT) Price Target to $117 | MDT Stock News

11 days ago - GuruFocus

Goldman Sachs Upgrades Medtronic (MDT) Following Strong Q2 Results

Goldman Sachs Upgrades Medtronic (MDT) Following Strong Q2 Results

11 days ago - GuruFocus

RBC Capital Raises Price Target for Medtronic (MDT) on November 19 | MDT Stock News

RBC Capital Raises Price Target for Medtronic (MDT) on November 19 | MDT Stock News

11 days ago - GuruFocus

Medtronic's Q2 Beat Rekindles Growth Story — But Analysts Say It's Not Enough Yet

Shares of Medtronic PLC (NYSE: MDT) inched higher in early trading on Wednesday, as the company on Tuesday reported strong fiscal second-quarter results . MDT is approaching key resistance levels. Fo...

11 days ago - Benzinga